3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Burkitt Lymphoma
14
Vomiting
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Nausea
5
Leukemia
5
Recurrence
4
Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Immunoglobulin Light-chain Amyloidosis
3
Breast Neoplasms
3
Blast Crisis
3
Smoldering Multiple Myeloma
2
Sarcoma
2
Prostatic Neoplasms
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmacytoma
2
Ovarian Neoplasms
2
Neoplasms, Plasma Cell
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Interventions
Hydroxyurea
3
Bevacizumab
3
pembrolizumab
2
Imatinib Mesylate
2
Everolimus
2
vistusertib
1
vatalanib
1
pasireotide
1
fludarabine phosphate
1
fludarabine
1
arginyllysine
1
antineoplaston AS 2-1
1
antineoplaston A10
1
aldesleukin
1
Whole Body Imaging
1
Verapamil
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiosurgery
1
Proton Therapy
1
Nivolumab
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
HDAC-42
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Meningioma
×
dexamethasone acetate
×
Clear all
No trials found.